Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Klaus Fuchs is active.

Publication


Featured researches published by Klaus Fuchs.


EMBO Reports | 2001

Presenilin‐dependent γ‐secretase processing of β‐amyloid precursor protein at a site corresponding to the S3 cleavage of Notch

Magdalena Sastre; Harald Steiner; Klaus Fuchs; Anja Capell; Gerd Multhaup; Margaret M. Condron; David B. Teplow; Christian Haass

The presenilin (PS)‐dependent site 3 (S3) cleavage of Notch liberates its intracellular domain (NICD), which is required for Notch signaling. The similar γ‐secretase cleavage of the β‐amyloid precursor protein (βAPP) results in the secretion of amyloid β‐peptide (Aβ). However, little is known about the corresponding C‐terminal cleavage product (CTFγ). We have now identified CTFγ in brain tissue, in living cells, as well as in an in vitro system. Generation of CTFγ is facilitated by PSs, since a dominant‐negative mutation of PS as well as a PS gene knock out prevents its production. Moreover, γ‐secretase inhibitors, including one that is known to bind to PS, also block CTFγ generation. Sequence analysis revealed that CTFγ is produced by a novel γ‐secretase cut, which occurs at a site corresponding to the S3 cleavage of Notch.


Alzheimers & Dementia | 2017

PDE9 INHIBITION IMPROVES COGNITION IN MICE BY A MECHANISM DIFFERENT FROM THE ACETYLCHOLINE ESTERASE INHIBITOR DONEPEZIL

Holger Rosenbrock; Riccardo Giovannini; Klaus Fuchs; Cornelia Dorner-Ciossek

Selaginella delicatula a pteridophyte (popularly known as Sanjeevani) is reported to contain characteristic biflavonoids (amentoflavone) with various biological activities in vitro. In this study, we have tested the hypothesis whether Selaginella flavonoids (SF) possess the potential to abrogate the lipopolysaccharide (LPS)induced biochemical and phenotypic alterations in Drosophila and mice models. Methods: First regimen, mice provided prophylaxis with (SF, 25 & 50mg/kg/d, p.o., for 15d, n1⁄46) were challenged with LPS (0.5mg/kg/d, ip, last 5 days). Phenotypic manifestations were assessed by employing a battery of behavioral assays for dementia (elevated plus maze, Y-maze, Morris water maze, passive avoidance). Hippocampus region was subjected to biochemical assessments viz., mitochondrial dysfunction, oxidative stress and AChE activity. Second regimen, adult Drosophila (n1⁄425, 6 replicates) maintained on SF enriched diet (0.05-0.1%, 7 days), were challenged with LPS (200mg, filter discs) and subsequently subjected to behavioral and biochemical tests. Results:LPS exposure induced significant behavioral aberrations among mice as evident from mazes. The passive avoidance score was markedly reduced among the LPS mice indicating severe dementia traits. Interestingly, the extent of LPS-induced behavioral anomalies among mice given SF prophylaxis was significantly attenuated. Additionally SF mice exhibited reduced oxidative stress markers, nitric oxide levels, diminished AChE activity and improved mitochondrial membrane permeability. In the Drosophila we could reproduce the protective effects of SF prophylaxis as evidenced by diminished LPS-induced general aggressive behavior, oxidative markers and AChE activity. Conclusions:These in vivo data are suggestive of potent neuro-attenuatory propensity of Selaginella flavonoids against LPS-induced dementia in mice and Drosophila and merit further mechanistic investigations.


Alzheimers & Dementia | 2015

Effects of the bace1 inhibitor bi 1181181 and the anti-abeta antibody m266 on abeta in rat brain homogenate and CSF

Scott Hobson; Martin Lenter; Achim Sauer; Klaus Fuchs; Deepak S. Lala; Lawrence Wayne Dillard; Cornelia Dorner-Ciossek

mice compared with wild-type mice, were significantly attenuated in FMeC1-treated APPswe/PS1dE9 mice. In the in vitro study, both curcumin and FMeC1 modulated the formation of Ab aggregates, however, only FMeC1 significantly attenuated cell toxicity of Ab. Conclusions: These results indicated that FMeC1 treatment inhibited the cognitive deficits and reduced Ab deposition and glial cell activation in the brain in APPswe/PS1dE9 mice. Thus we propose that the C-4 curcumin derivative, FMeC1 may be a useful candidate for preventing AD.


Archive | 2006

COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

Klaus Fuchs; Christian Eickmeier; Niklas Heine; Stefan Peters; Cornelia Dorner-Ciossek; Sandra Handschuh; Herbert Nar; Klaus Klinder


Archive | 2002

Novel tri-substituted pyrimidines, method for production and use thereof as medicament

Frank Himmelsbach; Klaus Fuchs; Hans Briem; Katja Fechteler; Markus Kostka; Cornelia Dorner-Ciossek; Klaus Bornemann; Klaus Klinder


Archive | 2001

Beta-amyloid inhibitors, processes for preparing them, and their use in pharmaceutical compositions

Hans Briem; Klaus Mendla; Helmut Romig; Katja Fechteler; Klaus Fuchs


Archive | 2004

Statine derivatives for the treatment of alzheimer's disease

Cornelia Dorner-Ciossek; Klaus Fuchs; Sandra Handschuh; Marcus Kostka; Stefan Peters; Christian Haass


Archive | 2003

Gamma-secretase in vitro screening assay

Klaus Fuchs; Cornelia Dorner-Ciossek; Marcus Kostka; Christian Haass; Harald Steiner


Archive | 2009

1-heterocyclyl-1,5-dihydro-pyrazolo[3,4-d]pyrimidin-4-one derivatives and their use as pde9a modulators

Riccardo Giovannini; Cornelia Dorner-Ciossek; Christian Eickmeier; Dennis Fiegen; Thomas Fox; Klaus Fuchs; Niklas Heine; Holger Rosenbrock; Gerhard Schaenzle


Archive | 2008

1, 5-DIHYDRO-PYRAZOLO (3, 4-D) PYRIMIDIN-4-ONE DERIVATIVES AND THEIR USE AS PDE9A MODULATORS FOR THE TEATMENT OF CNS DISORDERS

Christian Eickmeier; Cornelia Dorner-Ciossek; Dennis Fiegen; Thomas Fox; Klaus Fuchs; Riccardo Giovannini; Niklas Heine; Martin Hendrix; Holger Rosenbrock; Gerhard Schaenzle

Collaboration


Dive into the Klaus Fuchs's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge